Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Moderna
Biotech
Moderna flu vaccine beats approved competitor in fresh ph. 3 win
The long and winding journey of Moderna’s mRNA flu vaccine toward regulators has come one step closer with a phase 3 win over an approved competitor.
James Waldron
Jun 30, 2025 8:05am
HHS axes Moderna's $590M pandemic bird flu vaccine contract
May 29, 2025 4:30am
Moderna withdraws FDA filing for flu/COVID combination vaccine
May 21, 2025 9:35am
Vertex takes $379M hit tied to cancelled islet cell program
May 6, 2025 12:50pm
Moderna's flu/COVID vaccine hit by deprioritization, FDA delay
May 1, 2025 7:24am
FDA rocked by leadership shake-ups—Chutes & Ladders
Apr 4, 2025 8:30am
